Front Immunol April 2021 PMID 32983115

Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases.

Louise Magnusson, Daniel Espes, Rosaura Casas, Per-Ola Carlsson

Mentions

2
Peak: 1 in Sep 2020
across 2 sources since Sep 2020

Extended reach

34,316
potential audience

Total likes

9

Video views

389

Mentions per month

Sep 2020 – Nov 2025

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

Most discussions highlight the importance of identifying proteins like CDCP1 and SLAMF1 in autoimmune conditions, with phrases such as 'new insights' and 'potential breakthroughs' emphasizing their significance. The tone remains cautiously optimistic, reflecting curiosity and recognition of the study's relevance without overstatement.

AgreementModerate agreement

A majority of the discussions acknowledge the significance of the research findings, indicating general agreement on its importance.

InterestModerate interest

Posts show moderate interest, with some discussions referencing the potential implications but not delving deeply into specifics.

EngagementModerate engagement

Users are engaging by sharing summaries and commenting on the relevance of the proteins to autoimmune diseases, showing curiosity and some depth.

ImpactModerate impact

The collective tone suggests the findings are seen as potentially impactful for understanding autoimmune mechanisms, though not universally deemed transformative.

Abstract in brief

  • The study uses advanced protein detection techniques to compare immune-related proteins in blood samples from patients with various autoimmune endocrine diseases, including type 1 diabetes, Hashimoto's thyroiditis, Graves' disease, and Addison's disease, against healthy controls.
  • It found that specific proteins, such as CDCP1 and SLAMF1, were more abundant in patients' plasma, indicating increased inflammation and immune cell activation in these autoimmune conditions.
  • These findings suggest new links between these proteins and autoimmune endocrine diseases, potentially offering insights into their underlying immune mechanisms.

Top posts

Most liked on X and Bluesky
Frontiers - Immunology
@FrontImmunol · X

New Research: Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases: Despite that autoimmune diseases share similar immunogenetic mechanisms, studies comparing the protein… https://t.co/IWUUmA7RUG #immunology

Sep 28, 2020 · 5 likes · 33,928 followers View post →

All mentions

Frontiers - Immunology
@FrontImmunol · X

New Research: Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases: Despite that autoimmune diseases share similar immunogenetic mechanisms, studies comparing the protein… https://t.co/IWUUmA7RUG #immunology

Sep 28, 2020 · 5 likes · 33,928 followers View post →